This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Suresh's Most Recent Article

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

08/18/14 - 07:47 AM EDT

Spectrum's Beleodaq for Non-Hodgkin's lymphoma received FDA approval on July 3, but the stock then fell 26%. The same thing won't happen with Melphalan because sales numbers are already established.

read more >

Other Articles by Suresh

Free Reports

Why Toyota's Move to Fuel Cells Won't Affect Electric Vehicle Sales

07/31/14 - 02:48 PM EDT

Toyota is scrapping its electric vehicle line to go into fuel cells. Is this a step backwards? Not really.

read more >
Why Vertex Pharmaceuticals Will Likely Climb to New High

06/02/14 - 01:26 PM EDT

Vertex Pharmaceuticals is now within weeks, or even days, of announcing top-line results on its two phase 3 cystic fibrosis studies. The science, phase 2 data, and FDA approval history for cystic fibrosis all suggest that Vertex is about to explode higher.

read more >
Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs